Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Plos One|February 25, 2011
The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white womenGalina Lurie, Mia M Gaudet, Amanda B Spurdle, et al.Plos One|June 16, 2011
Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association ConsortiumGalina Lurie, Lynne R Wilkens, Pamela J Thompson, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 11, 2012
Polymorphisms in inflammation pathway genes and endometrial cancer riskRyan J Delahanty, Yong-Bing Xiang, Amanda Spurdle, et al.American Journal of Epidemiology|July 27, 2012
Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortiumVeronica Wendy Setiawan, Malcolm C Pike, Stalo Karageorgi, et al.Endocrine-Related Cancer|February 14, 2013
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association ConsortiumCatherine M Olsen, Christina M Nagle, David C Whiteman, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2012
Genome-wide association study identifies a possible susceptibility locus for endometrial cancerJirong Long, Wei Zheng, Yong-Bing Xiang, et al.Plos One|September 28, 2011
Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancersJonathan Beesley, Hilda A Pickett, Sharon E Johnatty, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2013
Type I and II endometrial cancers: have they different risk factors?Veronica Wendy Setiawan, Hannah P Yang, Malcolm C Pike, et al.The Lancet. Oncology|July 13, 2013
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium studyWeiva Sieh, Martin Köbel, Teri A Longacre, et al.Oncotarget|February 4, 2016
Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancerJuliet D French, Sharon E Johnatty, Yi Lu, et al.Pageof 4